Option Care Health, Inc. (NASDAQ:OPCH) Receives Consensus Rating of “Moderate Buy” from Brokerages

Option Care Health, Inc. (NASDAQ:OPCH) has earned an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, eight have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $37.2727.

Several analysts have issued reports on OPCH shares. Deutsche Bank Aktiengesellschaft upped their price objective on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, December 9th. Wall Street Zen downgraded Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, February 28th. Bank of America upped their price target on Option Care Health from $32.00 to $35.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Citizens Jmp restated a “market outperform” rating and set a $38.00 price objective (up from $36.00) on shares of Option Care Health in a research note on Tuesday, January 13th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th.

Option Care Health Price Performance

Shares of OPCH stock opened at $29.66 on Thursday. The firm has a fifty day moving average of $33.41 and a two-hundred day moving average of $30.75. The firm has a market cap of $4.64 billion, a P/E ratio of 23.17, a P/E/G ratio of 1.66 and a beta of 0.85. Option Care Health has a 1-year low of $24.24 and a 1-year high of $36.80. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.53 and a quick ratio of 0.96.

Option Care Health (NASDAQ:OPCH) last issued its earnings results on Tuesday, February 24th. The company reported $0.46 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.46. The business had revenue of $1.47 billion for the quarter, compared to analyst estimates of $1.46 billion. Option Care Health had a net margin of 3.67% and a return on equity of 18.57%. The company’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.44 EPS. As a group, research analysts anticipate that Option Care Health will post 1.22 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the business. Swedbank AB bought a new position in shares of Option Care Health during the third quarter valued at approximately $49,455,000. Boston Partners raised its position in shares of Option Care Health by 34.8% during the 2nd quarter. Boston Partners now owns 952,299 shares of the company’s stock worth $30,311,000 after purchasing an additional 245,990 shares during the period. Prudential Financial Inc. lifted its holdings in shares of Option Care Health by 32.6% in the 2nd quarter. Prudential Financial Inc. now owns 396,158 shares of the company’s stock worth $12,867,000 after purchasing an additional 97,465 shares during the last quarter. Aristides Capital LLC bought a new stake in shares of Option Care Health in the 2nd quarter worth approximately $249,000. Finally, Pacer Advisors Inc. acquired a new position in Option Care Health during the 3rd quarter valued at approximately $593,000. 98.05% of the stock is owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.